CollPlant Biotechnologies Announces Positive Results from non-clinical Studies of its Photocurable Regenerative Dermal and Soft Tissue Filler

CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies ...
Nasdaq

CollPlant Announces Development and Global Commercialization Agreement with Allergan Aesthetics, an AbbVie company, for rhCollagen in Dermal and Soft Tissue Filler Products

REHOVOT, Israel, Feb. 8, 2021 /PRNewswire/ -- CollPlant Biotechnologies (NASDAQ: CLGN) today announced it has entered into a worldwide exclusive development and commercialization agreement for dermal ...
TipRanks on MSN

CollPlant Biotechnologies Reports Positive Non-Clinical Results for Regenerative Filler

Collplant Holdings ( ($CLGN) ) has provided an update. On September 30, 2025, CollPlant Biotechnologies announced positive results from ...
Geelong Advertiser

ReNerve makes first sale in US$2.7bn dermal tissue repair market

ReNerve is complementing its nerve repair products in the US with a new dermal and amniotic product range, already achieving its first sale and clinical use. Special Report: ReNerve has completed the ...
Stockhead on MSN

ReNerve launches Empliq range targeting US dermal and amniotic tissue market

Developer of products for peripheral nerve repair ReNerve has launched its Empliq range in the US after recently completing ...
PBS

Crash Course Botany: Episode 4: What Do These Creepy Plant Mouths Do?

Plants—they’re just like us! Well, not exactly, but they do have skin and hair like us…even if they also have creepy little alien mouths. In this episode of Crash Course Botany, we’re getting up close ...
Pharmabiz

CollPlant announces positive results from non-clinical studies of its photocurable regenerative dermal and soft tissue filler

CollPlant announces positive results from non-clinical studies of its photocurable regenerative dermal and soft tissue filler: Rehovot, Israel Wednesday, October 1, 2025, 18:00 Hr ...